1. Clinical Overview
A fixed-dose combination (FDC) oral antidiabetic agent containing a third-generation sulfonylurea (Glimepiride) and a biguanide (Metformin). It is a cornerstone therapy for the management of Type 2 Diabetes Mellitus (T2DM) in Indian patients, particularly those inadequately controlled on monotherapy with either drug. Glimepiride stimulates insulin secretion from pancreatic beta-cells, while Metformin primarily reduces hepatic glucose production and improves insulin sensitivity. This combination provides complementary mechanisms for glycemic control.
| Onset | Duration | Bioavailability |
|---|---|---|
| Glimepiride: 1-2 hours; Metformin: 1-2 hours. | Glimepiride: Up to 24 hours (allows once-daily dosing); Metformin: 12-24 hours (dose-dependent). | Glimepiride: ~100%; Metformin: 50-60%. |
2. Mechanism of Action
The combination exerts a dual mechanism: Glimepiride binds to sulfonylurea receptors (SUR1) on pancreatic beta-cell membranes, leading to closure of ATP-sensitive potassium (K-ATP) channels, membrane depolarization, opening of voltage-gated calcium channels, and subsequent calcium influx triggering exocytosis of insulin granules. Metformin's primary action is to decrease hepatic gluconeogenesis and glycogenolysis. It also increases peripheral glucose uptake and utilization (especially in muscle) and may delay intestinal absorption of glucose.
3. Indications & Uses
- Type 2 Diabetes Mellitus (T2DM) in adults as second-line therapy when glycemic control is not achieved with either Glimepiride or Metformin monotherapy.
- T2DM in adults requiring both insulin secretion stimulation and reduction of insulin resistance.
4. Dosage & Administration
Adult Dosage: Usual starting dose: One tablet (Glimepiride 2mg + Metformin 1000mg) once daily with the first main meal (usually breakfast or the largest meal). Dose must be individualized based on glycemic response. Maximum recommended daily dose: Glimepiride 8mg + Metformin 2000mg. The Metformin 1000mg component is usually given in divided doses (e.g., 500mg twice daily), so this FDC is typically for patients already stabilized on such a regimen.
Administration: Take with meals to reduce gastrointestinal side effects from Metformin. Swallow whole with a glass of water; do not crush or chew. Maintain regular meal patterns to avoid hypoglycemia. Avoid excessive alcohol intake.
5. Side Effects
Common side effects may include:
- Hypoglycemia (due to Glimepiride)
- Nausea
- Diarrhea
- Vomiting
- Abdominal discomfort/pain
- Flatulence
- Asthenia (weakness)
- Headache
- Dizziness
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Other Antidiabetics (Insulin, Thiazolidinediones) | Increased risk of hypoglycemia. | Major |
| Beta-blockers (e.g., Propranolol) | May mask tachycardia (warning signs) of hypoglycemia; may potentiate hypoglycemic effect. | Moderate |
| Alcohol | Acute: Potentiates hypoglycemic effect of Glimepiride. Chronic: Increases risk of lactic acidosis with Metformin. | Major |
| Warfarin | Sulfonylureas may potentiate anticoagulant effect; monitor INR. | Moderate |
| CYP2C9 Inhibitors (e.g., Fluconazole, Amiodarone) | Increase Glimepiride plasma levels, risk of hypoglycemia. | Moderate |
| CYP2C9 Inducers (e.g., Rifampicin, Carbamazepine) | Decrease Glimepiride plasma levels, reducing efficacy. | Moderate |
| Cationic Drugs (e.g., Cimetidine, Ranitidine, Digoxin, Morphine, Vancomycin) | Competitively inhibit renal tubular secretion of Metformin, potentially increasing its levels. | Moderate |
| Diuretics (especially Thiazides, Loop diuretics) | May cause hyperglycemia, reducing antidiabetic efficacy. | Moderate |
| Corticosteroids (Systemic) | Cause hyperglycemia, requiring dose adjustment. | Major |
| Iodinated Contrast Media | Risk of lactic acidosis and acute renal failure. Metformin must be withheld. | Major |
7. Patient Counselling
- DO take the tablet with your first main meal of the day.
- DO monitor your blood glucose levels regularly as advised by your doctor.
- DO maintain a regular diet and exercise schedule.
- DO inform all your doctors and surgeons that you are taking this medicine.
- DO get your kidney function tested regularly.
- DONT skip meals after taking the medicine.
- DONT consume excessive alcohol.
- DONT take the medicine if you are fasting or have severe vomiting/diarrhea.
- DONT start any new medicine (including OTC, herbal) without consulting your doctor.
8. Toxicology & Storage
Overdose: Primarily manifests as HYPOGLYCEMIA: sweating, tremor, anxiety, blurred vision, hunger, palpitations, nausea, fatigue, headache, which can progress to confusion, drowsiness, loss of consciousness, seizures, coma, and neurological damage. Lactic acidosis symptoms may also occur with Metformin overdose: hyperventilation, abdominal pain, hypothermia, hypotension, bradycardia.
Storage: Store below 30°C. Protect from light and moisture. Keep the container tightly closed. Keep out of reach of children. Do not use after the expiry date printed on the pack.